Edwards Lifesciences (EW) EPS (Basic) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10% |
| Dec 31, 2025 | -26.13% |
| Sep 30, 2025 | -0.78% |
| Jun 30, 2025 | 37.14% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | 5.21% |
| Sep 30, 2024 | 63.49% |
| Jun 30, 2024 | 9.36% |
| Mar 31, 2024 | 6.19% |
| Dec 31, 2023 | 78.92% |
| Sep 30, 2023 | -12.62% |
| Jun 30, 2023 | -17.69% |
| Mar 31, 2023 | -12.94% |
| Dec 31, 2022 | 131.85% |
| Sep 30, 2022 | -7.45% |
| Jun 30, 2022 | -5.88% |
| Mar 31, 2022 | -11.25% |
| Dec 31, 2021 | -6.11% |
| Sep 30, 2021 | -3.58% |
| Jun 30, 2021 | 5.66% |
| Mar 31, 2021 | -4.22% |
| Dec 31, 2020 | -5.11% |
| Sep 30, 2020 | -1.12% |
| Jun 30, 2020 | -18.98% |
| Mar 31, 2020 | -2.59% |
| Dec 31, 2019 | -2.47% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -31.52% |
| Mar 31, 2019 | 7.39% |
| Dec 31, 2018 | -46.59% |
| Sep 30, 2018 | 9.37% |
| Jun 30, 2018 | 10.22% |
| Mar 31, 2018 | -4.90% |
| Dec 31, 2017 | -15.01% |
| Sep 30, 2017 | 6.19% |
| Jun 30, 2017 | 8.32% |
| Mar 31, 2017 | 13.84% |
| Dec 31, 2016 | 6.11% |
| Sep 30, 2016 | 7.96% |
| Jun 30, 2016 | 3.30% |
| Mar 31, 2016 | 3.65% |
| Dec 31, 2015 | 2.66% |
| Sep 30, 2015 | 5.54% |
| Jun 30, 2015 | 0.39% |
| Mar 31, 2015 | 6.30% |
| Dec 31, 2014 | 3.96% |
| Sep 30, 2014 | -7.51% |
| Jun 30, 2014 | 43.88% |